Synthesis and Evaluation of a Potential RSK2 Degrader in Human Multiple Myeloma Cell Lines
Chemical and Pharmaceutical Bulletin · 18.03.2026 · 74 (3) · 240-246
DOI: 10.1248/cpb.c25-00731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 18.03.2026. Verfasst von Daisuke Ide und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 1-5 Shimogamohangi-cho, Sakyo-ku, …. Hauptthemen laut MEDLINE: Multiple Myeloma, Ribosomal Protein S6 Kinases, 90-kDa, Antineoplastic Agents, Thalidomide. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 1-5 Shimogamohangi-cho, Sakyo-ku, Kyoto 606-0823, Japan.
- Medical Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan.
Zitieren
APA
Ide, D., Yokoo, H., Mizutani, S., Inoue, Y., Okamoto, H., Tsukamoto, T., Demizu, Y., Shimura, Y., Oba, M., & Kuroda, J. (2026). Synthesis and Evaluation of a Potential RSK2 Degrader in Human Multiple Myeloma Cell Lines. Chemical and Pharmaceutical Bulletin, 74(3), 240-246. https://doi.org/10.1248/cpb.c25-00731
Vancouver
Ide D, Yokoo H, Mizutani S, Inoue Y, Okamoto H, Tsukamoto T, et al. Synthesis and Evaluation of a Potential RSK2 Degrader in Human Multiple Myeloma Cell Lines. Chemical and Pharmaceutical Bulletin. 2026;74(3):240-246. doi:10.1248/cpb.c25-00731
BibTeX
@article{Ide2026,
author = {Ide, Daisuke and Yokoo, Hidetomo and Mizutani, Shinsuke and Inoue, Yu and Okamoto, Haruya and Tsukamoto, Taku and Demizu, Yosuke and Shimura, Yuji and Oba, Makoto and Kuroda, Junya},
title = {Synthesis and Evaluation of a Potential RSK2 Degrader in Human Multiple Myeloma Cell Lines},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2026},
volume = {74},
number = {3},
pages = {240--246},
doi = {10.1248/cpb.c25-00731}
}
EUVIMED